Search contract descriptions, companies and agencies.
COVID-19 - REMDESIVIR FOR INJECTION 100MG VIALS LYOPHILIZED POWDER
Total Committed
$10.8M
Product or Service Description
Drugs and Biologicals
Contracting Agency
Effective Date
Dec. 4, 2020
Funding Department
DEPT OF VETERANS AFFAIRS
Type
Firm fixed price
Solicitation Procedure
Subject to multiple award fair opportunity
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | REMDESIVIR FOR INJECTION 100MG/VIALS LYOPHILIZED POWDER | Feb. 24, 2021 | $46,710 | |
| GILEAD SCIENCES, INC. | REQUEST FUNDING TO PURCHASE COVID-19 MEDICAL SUPPLIES (REMDESIVIR) | Feb. 23, 2021 | Other Administrative Action | $0 |
| GILEAD SCIENCES, INC. | VEKLURY REMDESIVIR 100MG | Jan. 21, 2021 | $77,850 | |
| GILEAD SCIENCES, INC. | DELIVERY ORDER FOR VEKLURY (REMDESIVIR) FOR THE NSSC CUSTOMERS. | Jan. 20, 2021 | $3,892,500 | |
| GILEAD SCIENCES, INC. | REMDESIVIR | Jan. 19, 2021 | $136,238 | |
| GILEAD SCIENCES, INC. | REMDESIVIR | Jan. 12, 2021 | $46,710 | |
| GILEAD SCIENCES, INC. | REMDESIVIR FOR COVID-19 TREATMENT | Jan. 11, 2021 | $194,625 | |
| GILEAD SCIENCES, INC. | COVID EMERGENCY REMDESIVIR FOR INJECTIONS | Jan. 6, 2021 | $155,700 | |
| GILEAD SCIENCES, INC. | COVID - GILEAD REMDESIVIR (VEKLURY) DRUG FOR INJECTIONS | Dec. 24, 2020 | $291,938 | |
| GILEAD SCIENCES, INC. | VEKLURY (REMDESIVIR) 100MG LYPH PWD 20ML SDV | Dec. 23, 2020 | $77,850 | |
| GILEAD SCIENCES, INC. | COVID-19 - REMDESIVIR FOR INJECTION 100MG VIALS LYOPHILIZED POWDER | Dec. 23, 2020 | Other Administrative Action | $21,020 |
| GILEAD SCIENCES, INC. | REMDESIVIR - 100MG | Dec. 16, 2020 | $77,850 | |
| GILEAD SCIENCES, INC. | REMDESIVIR 100MG SOLID | Dec. 16, 2020 | $46,710 | |
| GILEAD SCIENCES, INC. | REMDESIVIR 100MG SOLID | Dec. 4, 2020 | $233,550 | |
| GILEAD SCIENCES, INC. | REMDESIVIR 100MG/VIAL INJ | Dec. 3, 2020 | $140,130 | |
| GILEAD SCIENCES, INC. | DELIVERY ORDER FOR VEKLURY (REMDESIVIR) FOR THE NSSC CUSTOMERS. | Nov. 30, 2020 | $3,892,500 | |
| GILEAD SCIENCES, INC. | 100MG REMDESIVIR LYOPHILIZED SOLID | Nov. 25, 2020 | $116,775 | |
| GILEAD SCIENCES, INC. | REMDESIVIR 100MG LYOPHILIZED SOLID | Nov. 24, 2020 | $19,463 | |
| GILEAD SCIENCES, INC. | COVID-19 REMDESIVIR 100MG MEDICATION IC | Nov. 17, 2020 | $291,938 | |
| GILEAD SCIENCES, INC. | INV-REMDESIVIR 100MG (COVID-19) | Nov. 10, 2020 | $175,163 | |
| GILEAD SCIENCES, INC. | COVID-19 EMERGENCY VEKLURY REMDESIVIR - CI | Nov. 9, 2020 | $291,938 | |
| GILEAD SCIENCES, INC. | REMDESIVIR COVID-19 TREATMENT | Nov. 9, 2020 | $42,818 | |
| GILEAD SCIENCES, INC. | EMERGENCY SUPPLY - VEKLURY REMDESIVIR 437 | Nov. 5, 2020 | $89,917 | |
| GILEAD SCIENCES, INC. | REMDESIVIR | Nov. 4, 2020 | $21,409 | |
| GILEAD SCIENCES, INC. | INV-REMDESIVIR 100MG (COVID-19) | Nov. 3, 2020 | $155,700 | |
| GILEAD SCIENCES, INC. | REMDESIVIR 100MG LYOPHILIZED SOLID (COVID-19) | Nov. 3, 2020 | $194,625 | |
| GILEAD SCIENCES, INC. | COVID-19 - REMDESIVIR FOR INJECTION 100MG VIALS LYOPHILIZED POWDER | Oct. 28, 2020 | $46,710 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.